Nevro Corp Net Worth

Nevro Corp Net Worth Breakdown

  NVRO
The net worth of Nevro Corp is the difference between its total assets and liabilities. Nevro Corp's net worth represents the value of the company's equity or ownership interest. In other words, it is the amount of money that would be left over if all of Nevro Corp's assets were sold and all of its debts were paid off. Net worth is sometimes referred to as shareholder's equity or book value. Nevro Corp's net worth can be used as a measure of its financial health and stability which can help investors to decide if Nevro Corp is a good investment. It is also essential in determining the company's creditworthiness and ability to secure financing before investing in Nevro Corp stock.

Nevro Corp Net Worth Analysis

Nevro Corp's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including Nevro Corp's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of Nevro Corp's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform Nevro Corp's net worth analysis. One common approach is to calculate Nevro Corp's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares Nevro Corp's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing Nevro Corp's net worth. This approach calculates the present value of Nevro Corp's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of Nevro Corp's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate Nevro Corp's net worth. This involves comparing Nevro Corp's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into Nevro Corp's net worth relative to its peers.

Enterprise Value

1.51 Billion

To determine if Nevro Corp is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Nevro Corp's net worth research are outlined below:
Nevro Corp had very high historical volatility over the last 90 days
The company reported the previous year's revenue of 425.17 M. Net Loss for the year was (92.21 M) with profit before overhead, payroll, taxes, and interest of 285.09 M.
Nevro Corp currently holds about 310.82 M in cash with (58.83 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 8.78, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Nevro Corp has a poor financial position based on the latest SEC disclosures
Over 96.0% of the company shares are owned by institutional investors
Latest headline from news.google.com: Nevro Stock Falls Despite Q4 Sales Beat on Strong SCS Demand - Yahoo Finance
Nevro Corp uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Nevro Corp. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Nevro Corp's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
21st of February 2024
Upcoming Quarterly Report
View
24th of April 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
15th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Nevro Corp Target Price Consensus

Nevro target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Nevro Corp's target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
   16  Hold
Most Nevro analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Nevro stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Nevro Corp, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice   Exposure   Valuation

Nevro Corp Target Price Projection

Nevro Corp's current and average target prices are 5.13 and 5.60, respectively. The current price of Nevro Corp is the price at which Nevro Corp is currently trading. On the other hand, Nevro Corp's target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.

Current Price

Nevro Corp Market Quote on 23rd of January 2025

Low Price4.68Odds
High Price5.13Odds

5.13

Target Price

Analyst Consensus On Nevro Corp Target Price

Low Estimate5.1Odds
High Estimate6.22Odds

5.6

Historical Lowest Forecast  5.1 Target Price  5.6 Highest Forecast  6.22
Note that most analysts generally publish their price targets in research reports on specific companies, along with recommendations for the company's stock.Although price targets are often quoted in the financial news media, there could be a delay between the publication of the latest analyst outlook on Nevro Corp and the information provided on this page.

Know Nevro Corp's Top Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Nevro Corp is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Nevro Corp backward and forwards among themselves. Nevro Corp's institutional investor refers to the entity that pools money to purchase Nevro Corp's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares
Assenagon Asset Management Sa2024-09-30
929.3 K
Geode Capital Management, Llc2024-09-30
835.2 K
State Street Corp2024-09-30
752.6 K
Palo Alto Investors, Llc2024-09-30
750.4 K
Jacobs Levy Equity Management, Inc.2024-09-30
732.7 K
Kent Lake Capital Llc2024-06-30
639.8 K
Citadel Advisors Llc2024-09-30
536.1 K
Balyasny Asset Management Llc2024-09-30
505.3 K
Millennium Management Llc2024-09-30
471.7 K
Arrowmark Colorado Holdings, Llc (arrowmark Partners)2024-09-30
4.4 M
Armistice Capital, Llc2024-09-30
3.7 M
Note, although Nevro Corp's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Follow Nevro Corp's market capitalization trends

The company currently falls under 'Small-Cap' category with a current market capitalization of 175.37 M.

Market Cap

662.04 Million

Project Nevro Corp's profitablity

Last ReportedProjected for Next Year
Return On Tangible Assets(0.16)(0.15)
Return On Capital Employed(0.16)(0.17)
Return On Assets(0.13)(0.14)
Return On Equity(0.28)(0.30)
The company has Profit Margin (PM) of (0.17) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.16) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.16.
When accessing Nevro Corp's net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures Nevro Corp's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Nevro Corp's profitability and make more informed investment decisions.

Evaluate Nevro Corp's management efficiency

Nevro Corp has return on total asset (ROA) of (0.0902) % which means that it has lost $0.0902 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.2478) %, meaning that it created substantial loss on money invested by shareholders. Nevro Corp's management efficiency ratios could be used to measure how well Nevro Corp manages its routine affairs as well as how well it operates its assets and liabilities. As of the 23rd of January 2025, Return On Tangible Assets is likely to grow to -0.15. In addition to that, Return On Capital Employed is likely to drop to -0.17. At this time, Nevro Corp's Non Current Assets Total are very stable compared to the past year. As of the 23rd of January 2025, Intangible Assets is likely to grow to about 33 M, while Total Assets are likely to drop about 461.8 M.
Last ReportedProjected for Next Year
Book Value Per Share 9.37  8.90 
Tangible Book Value Per Share 7.28  6.91 
Enterprise Value Over EBITDA(10.25)(10.76)
Price Book Value Ratio 2.38  2.26 
Enterprise Value Multiple(10.25)(10.76)
Price Fair Value 2.38  2.26 
Enterprise Value802.7 M1.5 B
The strategic initiatives led by Nevro Corp's management are central to its market success. By analyzing these initiatives, we provide a clear picture of the stock's growth prospects.
Enterprise Value Revenue
0.3654
Revenue
419.1 M
Quarterly Revenue Growth
(0.07)
Revenue Per Share
11.404
Return On Equity
(0.25)
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Nevro Corp insiders, such as employees or executives, is commonly permitted as long as it does not rely on Nevro Corp's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Nevro Corp insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Nevro Corp Corporate Filings

8K
14th of January 2025
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
F4
6th of January 2025
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
10Q
12th of November 2024
Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations
ViewVerify
13A
8th of November 2024
An amended filing to the original Schedule 13G
ViewVerify
Nevro Corp time-series forecasting models is one of many Nevro Corp's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Nevro Corp's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Nevro Corp Earnings Estimation Breakdown

The calculation of Nevro Corp's earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of Nevro Corp is estimated to be -0.582 with the future projection ranging from a low of -0.6475 to a high of -0.495. Please be aware that this consensus of annual earnings estimates for Nevro Corp is based on EPS before non-recurring items and includes expenses related to employee stock options.
Last Reported EPS
-0.41
-0.65
Lowest
Expected EPS
-0.582
-0.49
Highest

Nevro Corp Earnings Projection Consensus

Suppose the current estimates of Nevro Corp's value are higher than the current market price of the Nevro Corp stock. In this case, investors may conclude that Nevro Corp is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and Nevro Corp's stock will quickly adjusts to the new information provided by the consensus estimate.
Number of AnalystsHistorical AccuracyLast Reported EPSEstimated EPS for 31st of December 2024Current EPS (TTM)
1654.33%
-0.41
-0.582
-1.87

Nevro Corp Earnings per Share Projection vs Actual

Actual Earning per Share of Nevro Corp refers to what the company shows during its earnings calls or quarterly reports. The Expected EPS is what analysts covering Nevro Corp predict the company's earnings will be in the future. The higher the earnings per share of Nevro Corp, the better is its profitability. While calculating the Earning per Share, we use the weighted ratio, as the number of shares outstanding can change over time.

Nevro Corp Estimated Months Earnings per Share

For an investor who is primarily interested in generating an income out of investing in entities such as Nevro Corp, the EPS ratio can tell if the company is intending to increase its current dividend. Although EPS is an essential tool for investors, it should not be used in isolation. EPS of Nevro Corp should always be considered in relation to other companies to make a more educated investment decision.

Nevro Quarterly Analyst Estimates and Surprise Metrics

Earnings surprises can significantly impact Nevro Corp's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2024-11-11
2024-09-30-0.81-0.410.449 
2024-08-06
2024-06-30-0.68-0.530.1522 
2024-05-07
2024-03-31-1.05-0.580.4744 
2024-02-21
2023-12-31-0.49-0.250.2448 
2023-11-01
2023-09-30-0.77-0.650.1215 
2023-08-01
2023-06-30-0.69-0.690.0
2023-04-26
2023-03-31-1.04-0.980.06
2023-02-16
2022-12-31-0.49-0.54-0.0510 
2022-11-02
2022-09-30-0.12.222.322320 
2022-08-03
2022-06-30-0.82-0.710.1113 
2022-05-04
2022-03-31-1.1-0.980.1210 
2022-02-23
2021-12-31-0.86-0.860.0
2021-11-08
2021-09-30-0.87-0.860.01
2021-08-04
2021-06-30-0.73-0.620.1115 
2021-05-05
2021-03-31-0.84-0.85-0.01
2021-02-24
2020-12-31-0.33-0.210.1236 
2020-11-05
2020-09-30-0.59-0.290.350 
2020-08-05
2020-06-30-1.62-1.210.4125 
2020-05-05
2020-03-31-0.99-0.780.2121 
2020-02-25
2019-12-31-0.62-0.440.1829 
2019-11-06
2019-09-30-0.85-0.580.2731 
2019-08-08
2019-06-30-0.97-0.910.06
2019-05-09
2019-03-31-0.67-1.45-0.78116 
2019-02-21
2018-12-31-0.21-0.32-0.1152 
2018-11-05
2018-09-30-0.29-0.37-0.0827 
2018-08-02
2018-06-30-0.31-0.35-0.0412 
2018-05-07
2018-03-31-0.32-0.59-0.2784 
2018-02-22
2017-12-31-0.14-0.15-0.01
2017-11-06
2017-09-30-0.22-0.210.01
2017-08-07
2017-06-30-0.3-0.4-0.133 
2017-05-08
2017-03-31-0.25-0.5-0.25100 
2017-02-23
2016-12-31-0.2-0.34-0.1470 
2016-11-07
2016-09-30-0.4-0.140.2665 
2016-08-08
2016-06-30-0.47-0.260.2144 
2016-05-09
2016-03-31-0.65-0.330.3249 
2016-02-29
2015-12-31-0.56-0.510.05
2015-11-09
2015-09-30-0.75-0.70.05
2015-08-06
2015-06-30-0.89-0.770.1213 
2015-05-11
2015-03-31-0.63-0.570.06
2015-03-18
2014-12-31-0.54-0.59-0.05
2014-12-02
2014-09-30-0.72-0.480.2433 

Nevro Corp Corporate Directors

Elizabeth WeathermanIndependent DirectorProfile
Brad ValeIndependent DirectorProfile
Kevin OBoyleIndependent DirectorProfile
Shawn McCormickIndependent DirectorProfile
When determining whether Nevro Corp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Nevro Corp's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Nevro Corp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Nevro Corp Stock:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nevro Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
To learn how to invest in Nevro Stock, please use our How to Invest in Nevro Corp guide.
You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nevro Corp. If investors know Nevro will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Nevro Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.87)
Revenue Per Share
11.404
Quarterly Revenue Growth
(0.07)
Return On Assets
(0.09)
Return On Equity
(0.25)
The market value of Nevro Corp is measured differently than its book value, which is the value of Nevro that is recorded on the company's balance sheet. Investors also form their own opinion of Nevro Corp's value that differs from its market value or its book value, called intrinsic value, which is Nevro Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nevro Corp's market value can be influenced by many factors that don't directly affect Nevro Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Nevro Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Nevro Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nevro Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.